Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,711 recalls, newest first

Class II · Moderate risk

Clarithromycin Tablets

cGMP Deviations; products being recalled in response to a recall notice from the manufacturer, Wockhardt Limited, following a FDA inspection which noted inadequate investigation of market complaints, resulting in unsuccessful identification of root causes, and the investigation not being expanded to prevent repeat failure

Terminated cGMP deviation Blenheim Pharmacal, Inc. NDC 10544-522-20 D-1110-2015
Class II · Moderate risk

Captopril Tablets

cGMP Deviations; products being recalled in response to a recall notice from the manufacturer, Wockhardt Limited, following a FDA inspection which noted inadequate investigation of market complaints, resulting in unsuccessful identification of root causes, and the investigation not being expanded to prevent repeat failure

Terminated cGMP deviation Blenheim Pharmacal, Inc. NDC 10544-175-30 D-1109-2015
Class I · High risk

Morphine Sulfate

Sub-potent Drug; firm's analysis revealed subpotent result for morphine sulfate assay.

Terminated Wrong potency / content Pharmedium Services, LLC NDC 61553-401-44 D-0658-2016
Class II · Moderate risk

CONTRAVE (naltrexone HCl and bupropion HCl)

Failed Tablet/Capsule Specifications: Potential tablet defect of broken tablets and/or equatorial splitting of the bilayer tablets into the two drug components.

Terminated Failed specification Takeda Pharmaceuticals North America, Inc. NDC 64764-890-99 D-1206-2015
Class II · Moderate risk

SUCRETS Sore Throat & Cough Vapor Cherry lozenges

Labeling: Label Mix-Up: An incorrect book label for Sucrets Sore Throat, Cough & Dry Mouth Honey Lemon lozenges was applied to the underside of the Sucrets Sore Throat & Cough Vapor Cherry lozenges tin.

Terminated Labeling / mix-up Medtech Products, Inc. D-1113-2015

Recalls by year